Terms: = Breast cancer AND USP8, FLJ34456, 9101, ENSG00000138592, KIAA0055, P40818, MGC129718, UBPY, HumORF8 AND Treatment
8 results:
1. The discovery of potent USP2/usp8 dual-target inhibitors for the treatment of breast cancer via structure guided optimization of ML364.
Tian Y; Liu K; Wu D; Wu L; Xu Q; Wei W; Li Z; Du Q; Bian J
Eur J Med Chem; 2024 Mar; 268():116275. PubMed ID: 38452725
[TBL] [Abstract] [Full Text] [Related]
2. Discovery of Potent Small-Molecule usp8 Inhibitors for the treatment of breast cancer through Regulating ERα Expression.
Tian Y; Liu K; Liu R; Qiu Z; Xu Y; Wei W; Xu X; Wang J; Ding H; Li Z; Bian J
J Med Chem; 2022 Jul; 65(13):8914-8932. PubMed ID: 35786929
[TBL] [Abstract] [Full Text] [Related]
3. usp8 promotes tumor cell migration through activating the JNK pathway.
Zhao Y; Peng D; Liu Y; Zhang Q; Liu B; Deng Y; Ding W; Zhou Z; Liu Q
Cell Death Dis; 2022 Mar; 13(3):286. PubMed ID: 35361778
[TBL] [Abstract] [Full Text] [Related]
4. The anti-HER3 (ErbB3) therapeutic antibody 9F7-F11 induces HER3 ubiquitination and degradation in tumors through JNK1/2- dependent ITCH/AIP4 activation.
Le Clorennec C; Lazrek Y; Dubreuil O; Larbouret C; Poul MA; Mondon P; Melino G; Pèlegrin A; Chardès T
Oncotarget; 2016 Jun; 7(24):37013-37029. PubMed ID: 27203743
[TBL] [Abstract] [Full Text] [Related]
5. Pharmacokinetics and pharmacogenetics of capecitabine and its metabolites following replicate administration of two 500 mg tablet formulations.
Queckenberg C; Erlinghagen V; Baken BC; Van Os SH; Wargenau M; Kubeš V; Peroutka R; Novotný V; Fuhr U
Cancer Chemother Pharmacol; 2015 Nov; 76(5):1081-91. PubMed ID: 26242222
[TBL] [Abstract] [Full Text] [Related]
6. A case-matched study of stereotactic radiosurgery for patients with multiple brain metastases: comparing treatment results for 1-4 vs ≥ 5 tumors: clinical article.
Yamamoto M; Kawabe T; Sato Y; Higuchi Y; Nariai T; Barfod BE; Kasuya H; Urakawa Y
J Neurosurg; 2013 Jun; 118(6):1258-68. PubMed ID: 23600938
[TBL] [Abstract] [Full Text] [Related]
7. Aggressive treatment for hepatic metastases from breast cancer: results from a single center.
Polistina F; Costantin G; Febbraro A; Robusto E; Ambrosino G
World J Surg; 2013 Jun; 37(6):1322-32. PubMed ID: 23474856
[TBL] [Abstract] [Full Text] [Related]
8. Neuregulin-induced ErbB3 downregulation is mediated by a protein stability cascade involving the E3 ubiquitin ligase Nrdp1.
Cao Z; Wu X; Yen L; Sweeney C; Carraway KL
Mol Cell Biol; 2007 Mar; 27(6):2180-8. PubMed ID: 17210635
[TBL] [Abstract] [Full Text] [Related]
